Developer docs
API playgroundTry for free, no card

Search company profiles

CoolTech

Full company profile

uuid0000xmg

Namestring
CoolTech
Legal namestring
CoolTech LLC
Company typeenum
Private
Founded yearint
2011
Descriptiontext

CoolTech, operating as CoolTech Medical and legally CoolTech LLC, is a Maryland-based medical device company developing non-invasive transnasal cooling technology for targeted patient temperature management. Its sole product, the CoolStat device, delivers filtered, dry, room-temperature air in a unidirectional fashion through a nasal mask; the air flows over the highly vascularized nasal turbinates, where the phase change of liquid to gas extracts heat and induces systemic cooling without cooling pads, refrigeration carts, or external cooling systems. The device features closed-loop temperature control with operator-selectable targets, seamless hospital monitor and EMR integration, and a single-use air tubing consumable that minimizes infection risk.

The intended business model is a capital-equipment-plus-consumables hardware sale into hospitals and healthcare institutions once regulatory clearance is secured, distributed through enterprise field sales. The platform is being investigated across multiple indications: neurogenic (central) fever following stroke, traumatic brain injury, seizure, and metabolic encephalopathy (the lead indication, with the first multi-center clinical study completed in 2022); pre-hospital mild hypothermia induction post sudden cardiac arrest; and migraine pain reduction. The company currently has no commercial revenue and operates in a clinical-research-only distribution mode.

CoolTech employs 11–50 staff and has been supported by approximately $16 million in combined grants and private funding over its history, including a $1,135,000 private round in 2015, an Abell Foundation grant, a $200,000 seed from TEDCO in October 2022, and a $500,000 TEDCO follow-on in September 2025. It maintains a strategic co-development collaboration with Mi-Helper, Inc. on therapies for pain management and mood disorders, signaling intent to extend the technology beyond temperature management. The regulatory pathway (FDA clearance for the investigational CoolStat) remains the critical gating event for transitioning from a clinical-stage development company to a commercial medical device vendor.

Short descriptiontext

CoolTech is a Maryland-based medical device company developing the CoolStat transnasal cooling device, which uses evaporative cooling of dry air over nasal turbinates to provide non-invasive targeted temperature management for hospitals.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersToronto, United States
HQ citystring
Toronto
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
transnasal cooling devices, targeted temperature management, medical cooling technology, neurogenic fever treatment, patient temperature management
Industry1 code
PRIMARYHLAHACAK
Continuous Temperature & Fever Monitoring (Wearable Thermometry)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SIC code1 code
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Targeted Temperature Management Devices
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Device Sales (Future)
TypeHardware Sales
Description

Once regulatory clearance is obtained, CoolTech will generate revenue through the sale of the CoolStat device and associated single-use consumables (air tubing sets). The model will likely include capital equipment sales to hospitals with recurring revenue from disposable consumables.

cooltechcorp.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Operations, Personnel, Marketing or Sales, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1CoolStat
Description

A medical device for patient temperature management using evaporative cooling via transnasal dry air delivery. The device is designed for targeted temperature management (TTM) and is currently designated for investigational use only.

cooltechcorp.com
Core offering1 text field

CoolTech develops the CoolStat device, a portable investigational medical device that delivers filtered, dry, room temperature air through a nasal mask to induce systemic cooling via evaporative phase change at the highly vascularized nasal turbinates. The device features a closed-loop temperature control system that allows clinicians to set and automatically maintain a target patient temperature. CoolStat is currently designated for investigational use only and is being evaluated in clinical studies for neurogenic fever management, pre-hospital mild hypothermia post cardiac arrest, and migraine pain reduction.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Completed first multi-center clinical study in 2022 for neurogenic fever indication
+1 more record
Product overview1 text field

CoolTech is a medical device company with a single core product offering: the CoolStat device. CoolStat is a portable targeted temperature management system that uses a novel transnasal evaporative cooling approach to cool patients. Unlike traditional cooling methods using pads or refrigeration carts, CoolStat delivers dry room temperature air through a nasal mask, leveraging the highly vascularized nasal turbinates to induce systemic cooling. The device includes a closed-loop temperature control system and is designed for use in clinical settings for neurogenic fever management, post-cardiac arrest hypothermia initiation, and migraine pain reduction. The company is currently conducting clinical studies as the device has not yet been cleared or approved for commercial use.

Product and service1 record
1CoolStat
CategoryTargeted Temperature Management Devices
Description

CoolStat is a portable investigational medical device that delivers filtered, dry, room temperature air through a nasal mask to induce systemic cooling via evaporative phase change at the nasal turbinates. It includes a closed-loop temperature control system that allows clinicians to set and automatically maintain a target patient temperature. The device is currently designated for investigational use only and is being evaluated in clinical studies for neurogenic fever management, pre-hospital mild hypothermia induction post sudden cardiac arrest, and migraine pain reduction.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Mi-Helper, Inc.
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Mi-Helper, Inc. collaborates with distinguished scientists and clinicians at CoolTech on a mission to develop cutting-edge therapies for unmet needs in pain management and mood disorders. This collaboration supports the company's broader therapeutic applications beyond temperature management.

cooltechcorp.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers8 records
TypeDirect peer
Description

BrainCool markets RhinoChill, a transnasal cooling device for therapeutic hypothermia and fever management — the closest direct mechanism-level competitor to CoolTech's CoolStat, sharing both target indications and core evaporative/cooling technology.

TypeDirect peer
Description

EMCOOLS produces flexible surface cooling pads (Emcoolspad) and an intracranial cooling catheter (Cool Flow) for targeted temperature management, making it a direct competitor in TTM and fever control across overlapping clinical indications.

TypeBroad incumbent
Description

BD owns the Arctic Sun targeted temperature management system, the dominant surface-cooling platform in hospitals worldwide. It competes with CoolStat across neurogenic fever, cardiac arrest, and ICU temperature management as the entrenched TTM category leader.

TypeBroad incumbent
Description

ZOLL markets the Thermogard XP intravascular TTM platform widely used in post-cardiac arrest care and ICU normothermia. It is a broad incumbent in exactly the indications (cardiac arrest, fever management) CoolTech is pursuing.

TypeBroad incumbent
Description

Stryker's Altrix connects to multiple patient warming/cooling modalities across perioperative and critical care settings, providing an enterprise-scale TTM alternative that hospitals may prefer for installed-base and bundling reasons over a novel transnasal device.

TypeEmerging player
Description

Attune Medical's ensoETM is an esophageal cooling device for targeted temperature management in the ICU and cardiac arrest settings, positioning it as a differentiated emerging modality adjacent to CoolStat's transnasal approach.

TypeEmerging player
Description

Belmont Medical (a successor to Medivance-related assets) supplies high-flow fluid warming and rapid infusion devices used alongside TTM workflows in trauma and critical care, making it a comparable platform in the broader temperature/critical care space.

TypeOthers
Description

Vyaire Medical supplies respiratory care and ventilation products to hospitals, an ecosystem adjacency to CoolTech's nasal-interface cooling approach and a potential distribution/sales counterpart for hospital-channel go-to-market.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CoolTech

Targeted Temperature Management Devicescooltechcorp.com

CoolTech is a Maryland-based medical device company developing the CoolStat transnasal cooling device, which uses evaporative cooling of dry air over nasal turbinates to provide non-invasive targeted temperature management for hospitals.

What CoolTech does

CoolTech, operating as CoolTech Medical and legally CoolTech LLC, is a Maryland-based medical device company developing non-invasive transnasal cooling technology for targeted patient temperature management. Its sole product, the CoolStat device, delivers filtered, dry, room-temperature air in a unidirectional fashion through a nasal mask; the air flows over the highly vascularized nasal turbinates, where the phase change of liquid to gas extracts heat and induces systemic cooling without cooling pads, refrigeration carts, or external cooling systems. The device features closed-loop temperature control with operator-selectable targets, seamless hospital monitor and EMR integration, and a single-use air tubing consumable that minimizes infection risk.

The intended business model is a capital-equipment-plus-consumables hardware sale into hospitals and healthcare institutions once regulatory clearance is secured, distributed through enterprise field sales. The platform is being investigated across multiple indications: neurogenic (central) fever following stroke, traumatic brain injury, seizure, and metabolic encephalopathy (the lead indication, with the first multi-center clinical study completed in 2022); pre-hospital mild hypothermia induction post sudden cardiac arrest; and migraine pain reduction. The company currently has no commercial revenue and operates in a clinical-research-only distribution mode.

CoolTech employs 11–50 staff and has been supported by approximately $16 million in combined grants and private funding over its history, including a $1,135,000 private round in 2015, an Abell Foundation grant, a $200,000 seed from TEDCO in October 2022, and a $500,000 TEDCO follow-on in September 2025. It maintains a strategic co-development collaboration with Mi-Helper, Inc. on therapies for pain management and mood disorders, signaling intent to extend the technology beyond temperature management. The regulatory pathway (FDA clearance for the investigational CoolStat) remains the critical gating event for transitioning from a clinical-stage development company to a commercial medical device vendor.

CoolTech firmographics

Firmographics
Name
CoolTech
Legal name
CoolTech LLC
Website
https://cooltechcorp.com
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
11–50 employees
Short description
CoolTech is a Maryland-based medical device company developing the CoolStat transnasal cooling device, which uses evaporative cooling of dry air over nasal turbinates to provide non-invasive targeted temperature management for hospitals.
Ownership category
akta.pro rank

CoolTech industry classification

Industry
Product category
Targeted Temperature Management Devices
SIC
Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHACAK
Continuous Temperature & Fever Monitoring (Wearable Thermometry)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics

Keywords

  • Transnasal cooling devices
  • Targeted temperature management
  • Medical cooling technology
  • Neurogenic fever treatment
  • Patient temperature management

Where CoolTech is headquartered

Location

Headquarters

HQ city
Toronto
HQ country
United States
HQ region
North America

Offices1 record

Markets served

CoolTech business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Operations, Personnel, Marketing or Sales, Supply Chain

Revenue model

  1. Medical Device Sales (Future): Once regulatory clearance is obtained, CoolTech will generate revenue through the sale of the CoolStat device and associated single-use consumables (air tubing sets). The model will likely include capital equipment sales to hospitals with recurring revenue from disposable consumables.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

CoolTech product offering

Product offering

Core offering

CoolTech develops the CoolStat device, a portable investigational medical device that delivers filtered, dry, room temperature air through a nasal mask to induce systemic cooling via evaporative phase change at the highly vascularized nasal turbinates. The device features a closed-loop temperature control system that allows clinicians to set and automatically maintain a target patient temperature. CoolStat is currently designated for investigational use only and is being evaluated in clinical studies for neurogenic fever management, pre-hospital mild hypothermia post cardiac arrest, and migraine pain reduction.

Product overview

CoolTech is a medical device company with a single core product offering: the CoolStat device. CoolStat is a portable targeted temperature management system that uses a novel transnasal evaporative cooling approach to cool patients. Unlike traditional cooling methods using pads or refrigeration carts, CoolStat delivers dry room temperature air through a nasal mask, leveraging the highly vascularized nasal turbinates to induce systemic cooling. The device includes a closed-loop temperature control system and is designed for use in clinical settings for neurogenic fever management, post-cardiac arrest hypothermia initiation, and migraine pain reduction. The company is currently conducting clinical studies as the device has not yet been cleared or approved for commercial use.

Differentiator

Problem solved

Functional benefit

Brands

  • CoolStat: A medical device for patient temperature management using evaporative cooling via transnasal dry air delivery. The device is designed for targeted temperature management (TTM) and is currently designated for investigational use only.

Products and services

  • CoolStat CoolStat is a portable investigational medical device that delivers filtered, dry, room temperature air through a nasal mask to induce systemic cooling via evaporative phase change at the nasal turbinates. It includes a closed-loop temperature control system that allows clinicians to set and automatically maintain a target patient temperature. The device is currently designated for investigational use only and is being evaluated in clinical studies for neurogenic fever management, pre-hospital mild hypothermia induction post sudden cardiac arrest, and migraine pain reduction.

Quantifiable outcome

  • Completed first multi-center clinical study in 2022 for neurogenic fever indication
  • +1 more outcomes

Companies that use CoolTech

Customer profile

Segments2 records

Ideal customer profiles1 record

CoolTech technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature3 records

CoolTech partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Mi-Helper, Inc.minorStrategic or Co-development PartnerMi-Helper, Inc. collaborates with distinguished scientists and clinicians at CoolTech on a mission to develop cutting-edge therapies for unmet needs in pain management and mood disorders. This collaboration supports the company's broader therapeutic applications beyond temperature management.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

CoolTech competitors and assessment

Company assessment

Direct peers

  • BrainCool AB: BrainCool markets RhinoChill, a transnasal cooling device for therapeutic hypothermia and fever management — the closest direct mechanism-level competitor to CoolTech's CoolStat, sharing both target indications and core evaporative/cooling technology.
  • EMCOOLS: EMCOOLS produces flexible surface cooling pads (Emcoolspad) and an intracranial cooling catheter (Cool Flow) for targeted temperature management, making it a direct competitor in TTM and fever control across overlapping clinical indications.

Broad incumbents

  • Becton Dickinson (BD): BD owns the Arctic Sun targeted temperature management system, the dominant surface-cooling platform in hospitals worldwide. It competes with CoolStat across neurogenic fever, cardiac arrest, and ICU temperature management as the entrenched TTM category leader.
  • ZOLL Medical (Asahi Kasei): ZOLL markets the Thermogard XP intravascular TTM platform widely used in post-cardiac arrest care and ICU normothermia. It is a broad incumbent in exactly the indications (cardiac arrest, fever management) CoolTech is pursuing.
  • Stryker: Stryker's Altrix connects to multiple patient warming/cooling modalities across perioperative and critical care settings, providing an enterprise-scale TTM alternative that hospitals may prefer for installed-base and bundling reasons over a novel transnasal device.

Emerging players

  • Attune Medical: Attune Medical's ensoETM is an esophageal cooling device for targeted temperature management in the ICU and cardiac arrest settings, positioning it as a differentiated emerging modality adjacent to CoolStat's transnasal approach.
  • Belmont Medical Technologies: Belmont Medical (a successor to Medivance-related assets) supplies high-flow fluid warming and rapid infusion devices used alongside TTM workflows in trauma and critical care, making it a comparable platform in the broader temperature/critical care space.

Others

  • Vyaire Medical: Vyaire Medical supplies respiratory care and ventilation products to hospitals, an ecosystem adjacency to CoolTech's nasal-interface cooling approach and a potential distribution/sales counterpart for hospital-channel go-to-market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

CoolTech financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CoolTech leadership team

Management profile

Number of profiles

CoolTech funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CoolTech M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CoolTech

What does CoolTech do?

CoolTech develops the CoolStat device, a portable investigational medical device that delivers filtered, dry, room temperature air through a nasal mask to induce systemic cooling via evaporative phase change at the highly vascularized nasal turbinates. The device features a closed-loop temperature control system that allows clinicians to set and automatically maintain a target patient temperature. CoolStat is currently designated for investigational use only and is being evaluated in clinical studies for neurogenic fever management, pre-hospital mild hypothermia post cardiac arrest, and migraine pain reduction.

Is CoolTech a public or private company?

CoolTech is a private company. It is classified as venture growth investor backed and is currently operating.

When was CoolTech founded?

CoolTech was founded in 2011. It employs 11 to 50 people.

Where is CoolTech based?

CoolTech is headquartered in Toronto, United States, in the North America region.

How does CoolTech make money?

One revenue line is on record: medical Device Sales (Future).

Who are CoolTech's main competitors?

Direct peers on record are BrainCool AB and EMCOOLS. Broad incumbents are Becton Dickinson (BD), ZOLL Medical (Asahi Kasei) and Stryker. Emerging players are Attune Medical and Belmont Medical Technologies. Vyaire Medical is listed as an others.

Does CoolTech have an API?

No public API is recorded for CoolTech.

What industry is CoolTech in?

CoolTech's product category is Targeted Temperature Management Devices. Its primary akta.pro industry code is HLAHACAK, Continuous Temperature & Fever Monitoring (Wearable Thermometry). Its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals